Related references
Note: Only part of the references are listed.Posttransplant Soluble B-Cell Activating Factor Kinetics in Pediatric Recipients of First Kidney Allograft
Patrizia Comoli et al.
TRANSPLANTATION (2015)
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
M. Haas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Donor-specific antibodies in allograft recipients: etiology, impact and therapeutic approaches
Stanley C. Jordan et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2014)
Biomarkers for kidney transplant rejection
Denise J. Lo et al.
NATURE REVIEWS NEPHROLOGY (2014)
The BAFF/APRIL system in SLE pathogenesis
Fabien B. Vincent et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
The Banff classification revisited
Kim Solez et al.
KIDNEY INTERNATIONAL (2013)
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
Alexandre Loupy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
BAFF and Associated TNF Superfamily Members in Renal Transplantation: An End to BLySful Ignorance
Manu Chhabra et al.
TRANSPLANTATION (2013)
Elevated Pretransplantation Soluble BAFF Is Associated With an Increased Risk of Acute Antibody-Mediated Rejection
Gemma Banham et al.
TRANSPLANTATION (2013)
Trends and Characteristics in Early Glomerular Filtration Rate Decline After Posttransplantation Alloantibody Appearance
Pingping Wu et al.
TRANSPLANTATION (2013)
The Role of Immunoglobulin-G Subclasses and C1q in De Novo HLA-DQ Donor-Specific Antibody Kidney Transplantation Outcomes
Maria Cecilia S. Freitas et al.
TRANSPLANTATION (2013)
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
J. Sellares et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
C. Wiebe et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
BAFF and BAFF-R Levels Are Associated With Risk of Long-Term Kidney Graft Dysfunction and Development of Donor-Specific Antibodies
A. Thibault-Espitia et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Elevated serum levels of B-cell activating factor in pediatric renal transplant patients
Anja Lehnhardt et al.
PEDIATRIC NEPHROLOGY (2012)
APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis
Worapot Treamtrakanpon et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Targeting B Cells and Antibody in Transplantation
M. R. Clatworthy
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
The utility of 6-month protocol renal biopsy under modern immunosuppression
A. Yango et al.
CLINICAL NEPHROLOGY (2011)
Prevention and treatment of alloantibody-mediated kidney transplant rejection
Gregor Bartel et al.
TRANSPLANT INTERNATIONAL (2011)
BAFF Is Increased in Renal Transplant Patients Following Treatment with Alemtuzumab
D. Bloom et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Comparison of Combination Plasmapheresis/IVIg/Anti-CD20 Versus High-Dose IVIg in the Treatment of Antibody-Mediated Rejection
C. Lefaucheur et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
BAFF May Modulate the Rate of B-Cell Repopulation After Rituximab Therapy for Acute Renal Transplant Rejection
Valeriya Zarkhin et al.
TRANSPLANTATION (2009)
The Expression of B-Cell Activating Factor Belonging to Tumor Necrosis Factor Superfamily (BAFF) Significantly Correlated With C4D in Kidney Allograft Rejection
H. Xu et al.
TRANSPLANTATION PROCEEDINGS (2009)
Abnormal High Expression of B-Cell Activating Factor Belonging to the TNF Superfamily (BAFF) Associated With Long-Term Outcome in Kidney Transplant Recipients
H. Xu et al.
TRANSPLANTATION PROCEEDINGS (2009)
Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production
S. Morimoto et al.
RHEUMATOLOGY (2007)
Protocol transplant biopsies: Are they really needed?
Alan Wilkinson
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Share Paper
